𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dosage and schedule of mitomycin in clinical setting

✍ Scribed by Robert E. Huben

Book ID
119047178
Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
612 KB
Volume
40
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

5-fluorouracil, adriamycin, and mitomyci
5-fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy in advanced adenocarcinoma of the lung: comparison of two dosage schedules
✍ W. K. Lam; S. Y. So; T. M. Kung; M. K. Sham; Mary Ip πŸ“‚ Article πŸ“… 1987 πŸ› Springer 🌐 English βš– 254 KB

Fifty patients with inoperable adenocarcinoma of the lung were randomized in a prospective study to receive either standard doses or high doses of 5-fluorouracil, adriamycin, and mitomycin-C (FAM versus Hi-FAM). The response/stabilization rate was 32% for FAM and 34% for Hi-FAM (P greater than 0.05)

The Clinical Interview Schedule – Sinhal
The Clinical Interview Schedule – Sinhala version: validation in a community setting in Sri Lanka
✍ Shiranee Champika Wickramasinghe; Lalini Rajapakse; Ranil Abeysinghe; Martin Pri πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

## Abstract The Clinical Interview Schedule – Revised (CIS‐R) was validated in a clinic setting for adolescents 15–19 years of age in Sri Lanka. The interview schedule was translated into Sinhala and modified to include sections introducing each symptom group. One‐hundred‐and‐thirty‐one adolescents